BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 8782129)

  • 1. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
    Adachi JD; Bensen WG; Bianchi F; Cividino A; Pillersdorf S; Sebaldt RJ; Tugwell P; Gordon M; Steele M; Webber C; Goldsmith CH
    J Rheumatol; 1996 Jun; 23(6):995-1000. PubMed ID: 8782129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss.
    Adachi J; Cranney A; Goldsmith CH; Bensen WG; Bianchi F; Cividino A; Craig GL; Kaminska E; Sebaldt RJ; Papaioannou A
    J Rheumatol; 1994 Oct; 21(10):1922-6. PubMed ID: 7837160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
    Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
    J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
    McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
    AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
    J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
    Amin S; LaValley MP; Simms RW; Felson DT
    Arthritis Rheum; 1999 Aug; 42(8):1740-51. PubMed ID: 10446876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of calcium, calcitriol, and alendronate in corticosteroid-treated premenopausal patients with systemic lupus erythematosus.
    Yeap SS; Fauzi AR; Kong NC; Halim AG; Soehardy Z; Rahimah I; Chow SK; Goh EM
    J Rheumatol; 2008 Dec; 35(12):2344-7. PubMed ID: 19004038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in physicians' judgments about corticosteroid induced osteoporosis by physician specialty.
    Buckley LM; Marquez M; Hudson JO; Downs RW; Vacek P; Small RE; Poses R
    J Rheumatol; 1998 Nov; 25(11):2195-202. PubMed ID: 9818664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
    Cohen S; Levy RM; Keller M; Boling E; Emkey RD; Greenwald M; Zizic TM; Wallach S; Sewell KL; Lukert BP; Axelrod DW; Chines AA
    Arthritis Rheum; 1999 Nov; 42(11):2309-18. PubMed ID: 10555025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 36 month intermittent cyclical etidronate treatment in patients with established corticosteroid induced osteoporosis.
    Sebaldt RJ; Ioannidis G; Adachi JD; Bensen WG; Bianchi F; Cividino A; Gordon M; Kaminska E; Scocchia T; Petrie A; Stephenson GF; Goldsmith CH
    J Rheumatol; 1999 Jul; 26(7):1545-9. PubMed ID: 10405943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss.
    Adachi JD; Roux C; Pitt PI; Cooper C; Moniz C; Dequeker J; Ioannidis G; Cawley MI; Jenkins EA; Walker-Bone KE; Pack S; Stephenson GF; Laan RF; Brown J; Geusens P
    J Rheumatol; 2000 Oct; 27(10):2424-31. PubMed ID: 11036840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy.
    Warady BD; Lindsley CB; Robinson FG; Lukert BP
    J Rheumatol; 1994 Mar; 21(3):530-5. PubMed ID: 8006898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density changes in women with systemic lupus erythematosus.
    Boyanov M; Robeva R; Popivanov P
    Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin.
    Sambrook P; Birmingham J; Kelly P; Kempler S; Nguyen T; Pocock N; Eisman J
    N Engl J Med; 1993 Jun; 328(24):1747-52. PubMed ID: 7684512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis.
    Haworth CS; Jones AM; Adams JE; Selby PL; Webb AK
    J Cyst Fibros; 2004 Dec; 3(4):233-6. PubMed ID: 15698940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial.
    Adachi JD; Saag KG; Delmas PD; Liberman UA; Emkey RD; Seeman E; Lane NE; Kaufman JM; Poubelle PE; Hawkins F; Correa-Rotter R; Menkes CJ; Rodriguez-Portales JA; Schnitzer TJ; Block JA; Wing J; McIlwain HH; Westhovens R; Brown J; Melo-Gomes JA; Gruber BL; Yanover MJ; Leite MO; Siminoski KG; Nevitt MC; Sharp JT; Malice MP; Dumortier T; Czachur M; Carofano W; Daifotis A
    Arthritis Rheum; 2001 Jan; 44(1):202-11. PubMed ID: 11212161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis.
    Floreani A; Carderi I; Ferrara F; Rizzotto ER; Luisetto G; Camozzi V; Baldo V
    Dig Liver Dis; 2007 Jun; 39(6):544-8. PubMed ID: 17416215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.